It is a paper private limited company based in Serilingampally, Telangana, India, established in 2023.
2023 | Serilingampally, Telangana, India | ActiveRx-Infinity Therapeutics Private Limited, a active private limited company, was established on 31 May 2023 in Serilingampally, Telangana, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001TS2023PTC173621. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Ramadevi Amaram (Director), Manikanth Reddy Yarala (Director). Its latest AGM occurred on 27 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No.Mig-1139, Mayuri Nagar, Serilingampally, Telangana, 500049.
U21001TS2023PTC173621
173621
31 May 2023
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Rx-Infinity Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramadevi Amaram | Director | 31 May 2023 | Current |
| Manikanth Reddy Yarala | Director | 31 May 2023 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Rx-Infinity Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Rx-Infinity Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rx-Infinity Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rx-Infinity Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rx-Infinity Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rx-Infinity Therapeutics Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records. was completed.
Progress on Rx-Infinity Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Ramadevi Amaram was appointed as a Director was appointed as a Director on 31 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
Progress on Manikanth Reddy Yarala was appointed as a Director was appointed as a Director on 31 May 2023 & has been associated with this company since 2 years 7 months . was documented.
Rx-Infinity Therapeutics Private Limited was registered on 31 May 2023 with Roc Hyderabad & aged 2 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Rx-Infinity Therapeutics Private Limited is U21001TS2023PTC173621.
Rx-Infinity Therapeutics Private Limited is headquartered at H.No.Mig-1139, Mayuri Nagar, Serilingampally, Telangana, 500049.
Rx-Infinity Therapeutics Private Limited was incorporated on 31 May 2023.
The current directors of Rx-Infinity Therapeutics Private Limited are
The primary industry of Rx-Infinity Therapeutics Private Limited is Paper.
Rx-Infinity Therapeutics Private Limited is unlisted.
The authorized capital of Rx-Infinity Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX